Key Factor Supporting Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Development in 2025: Increasing Prevalence Of Autoimmune Disorders Is Fueling The Growth Of The Market Due To Rising Demand For Early Diagnosis And Personalize

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size By 2025?
In recent times, there has been a significant increase in the market size of the artificial intelligence (AI)-powered rare disease diagnosis sector. The industry, which was valued at $1.54 billion in 2024, is projected to reach a value of $1.99 billion in 2025, showcasing a Compound Annual Growth Rate (CAGR) of 29.1%. This exponential growth is due to factors such as the widespread adoption of AI in healthcare, an uptick in investment in rare disease research, heightening consciousness about early diagnosis, fortification of healthcare infrastructure, and increased government backing for digital health.

How Big Is the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Size Expected to Grow by 2029?
In the coming years, the market size for rare disease diagnosis facilitated by artificial intelligence (AI) is projected to witness rapid expansion. This market is predicted to reach $5.50 billion in 2029, with a compound annual growth rate (CAGR) of 28.9%. The growth expected during the forecast period is primarily due to the escalating incorporation of machine learning algorithms, the surge in demand for personalized healthcare, burgeoning partnerships between AI startups and hospitals, a burgeoning availability of genomic data, and a steady rise in digitalization in the healthcare sector. Major anticipated trends for this period encompass advancements in deep learning models, breakthroughs in predictive diagnostics, strides in the use of natural language processing for medical data, the evolution in multi-omics integration research and development, and unceasing enhancements in AI-powered imaging technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-rare-disease-diagnosis-global-market-report

Which Key Market Drivers Powering Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Expansion and Growth?
The escalating incidence of autoimmune diseases is anticipated to drive the expansion of the AI-enabled rare disease diagnosis market in the future. Autoimmune diseases represent a condition in which the immune system erroneously affects the body's own cells and tissues, resulting in inflammation and damage. The rise in autoimmune disorders can be attributed to the increasing amount of people suffering from immune system malfunctions, necessitating improved early detection, enhanced treatments, and consistent monitoring to manage symptoms effectively. AI-enabled rare disease diagnosis aids the management of autoimmune diseases by promptly identifying complex conditions, assisting with personalized treatment choices, and enhancing diagnostic precision overall. For example, in June 2024, the Australian Institute of Health and Welfare, a government organization based in Australia, reported that an estimated 514,000 individuals (2.0%) in Australia were battling rheumatoid arthritis (a systemic autoimmune disease where the immune system attacks its tissues) in 2022. Thus, the rising incidence of autoimmune diseases propels the expansion of the AI-powered rare disease diagnosis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28139&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
Leading firms active in the AI-enhanced rare disease detection market are honing in on inventive technologies, like consolidated genomic diagnostic systems, in order to advance diagnostic precision, expedite the process and provide a wider understanding of intricate genetic conditions. A consolidated genomic diagnostic system is a combined framework which joins whole-genome sequencing with AI-led evaluation to provide full-scale genetic insights. As an illustration, in October 2023, Oxford Nanopore Technologies plc, a British biotech firm, and Fabric Genomics Inc., an American AI-oriented company, unveiled a combined whole-genome sequencing solution devised to hasten the diagnosis of rare diseases. This is achieved by merging rapid sequencing with AI-assisted variant interpretation to achieve highly accurate and useful clinical discoveries. The introduction fuses real-time nanopore sequencing with AI-induced genomic analysis to swiftly pinpoint rare genetic variations. This tool provides wide-ranging, implementable discoveries for clinicians, augmenting diagnostic velocity and accuracy, particularly in pediatric care.

What Are the Emerging Segments in the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
The artificial intelligence (AI)-powered rare disease diagnosis market covered in this report is segmented as

1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies
3) By Deployment Mode: Cloud-Based, On-Premises
4) By Diagnosis Type: Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types
5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users

Subsegments:
1) By Software: Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software
2) By Hardware: Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors
3) By Services: Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28139&type=smp

Who Are the Global Leaders in the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
Major companies operating in the artificial intelligence (ai)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Facial Dysmorphology Novel Analysis, Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project.

Which are the Top Profitable Regional Markets for the Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Industry?
North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered rare disease diagnosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28139

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.